STOCKWATCH
·
Pharmaceuticals
Acquisitions9 Oct 2025, 03:15 pm

Fredun Pharmaceuticals Acquires Wagr.ai: A Revolutionary Partnership to Redefine India's Pet Care Industry

AI Summary

Fredun Pharmaceuticals Limited, a leading pharmaceuticals formulation manufacturing company, has announced the strategic acquisition of all assets of Wagr, a pet tech platform. This acquisition marks the launch of India's first truly neutral online marketplace for pet products and services, positioning FPL at the forefront of the rapidly growing pet care industry, projected to reach $6 billion by 2030. The acquisition includes Wagr's comprehensive technology platform, user base of 140,000+ pet parents, patented pet fitness tracking technology, and established veterinary network. FPL will relaunch the Wagr marketplace and services in Q4 FY 2025-26.

Key Highlights

  • Fredun Pharmaceuticals Limited acquires Wagr, a leading pet tech platform, marking the launch of India's first truly neutral online marketplace for pet products and services.
  • The acquisition includes Wagr's comprehensive technology platform, user base of 140,000+ pet parents, patented pet fitness tracking technology, and established veterinary network.
  • FPL's strategic positioning in functional food, wet food, and prescription food categories enables the company to maintain complete neutrality while hosting competing brands.
  • The integrated platform addresses the needs of India's burgeoning community of new pet parents through multiple support channels, including on-demand telemedicine, a pan-India doctor network, and Al-powered pet care.
  • FPL plans to reintroduce patented fitness tracking technology for pets in FY 2026-27.
FREDUN
Pharmaceuticals
Fredun Pharmaceuticals Ltd

Price Impact